Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas

Oncology Reports

Volumn 25, Issue 2, 2011, Pages 353-358

  Zhang, Xia ^a   Wang, Xiaoyan ^a   Song, Xingguo ^a   Wei, Zengtao ^b   Zhou, Chengjun ^c   Zhu, Faliang ^a   Wang, Qun ^a   Ma, Chunhong ^a   Zhang, Lining ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

Expression; Ovarian cancer; Prognosis; Programmed cell death 5

Indexed keywords

MEMBRANE PROTEIN; PROGRAMMED CELL DEATH 5; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CYSTADENOCARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CYSTADENOCARCINOMA, SEROUS; CYSTADENOMA, SEROUS; DOWN-REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 78651377064     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2010.1103     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Liu HT, Wang YG, Zhang YM, et al: TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254: 203-210, 1999.
3. Chen Y, Sun R, Han W, et al: Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett 509: 191-196, 2001.
4. Rui M, Chen Y, Zhang Y and Ma D: Transfer of anti-TFAR19 monoclonal antibody into HeLa cells by in situ electroporation can inhibit the apoptosis. Life Sci 71: 1771-1778, 2002. (Pubitemid 34876695)
5. Xie M, Niu JH, Chang Y, et al: A novel triple-regulated oncolytic adenovirus carrying PDCD5 gene exerts potent antitumor efficacy on common human leukemic cell lines. Apoptosis 14: 1086-1094, 2009.
6. Salvi M, Xu D, Chen Y, Cabrelle A, Sarno S and Pinna LA: Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells. Biochem Biophys Res Commun 387: 606-610, 2009.
7. Xu L, Chen Y, Song Q, Xu D, Wang Y and Ma D: PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis. Neoplasia 11: 345-354, 2009.
8. Yang YH, Zhao M, Li WM, et al: Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis 11: 993-1001, 2006. (Pubitemid 43876829)
9. Xu XR, Huang J, Xu ZG, et al: Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 98: 15089-15094, 2001. (Pubitemid 34013974)
10. Hedenfalk I, Duggan D, Chen Y, et al: Gene-expression profiles in hereditary breast cancer. N Engl J Med 344: 539-548, 2001. (Pubitemid 32167867)
11. Ruan GR, Qin YZ, Chen SS, et al: Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk Res 30: 1159-1165, 2006.
12. Li H, Wang Q, Gao F, et al: Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Oncol Rep 20: 573-579, 2008.
13. Schuijer M and Berns EM: TP53 and ovarian cancer. Hum Mutat 21: 285-291, 2003.
14. Herod JJ, Eliopoulos AG, Warwick J, Niedobitek G, Young LS and Kerr DJ: The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res 56: 2178-2184, 1996. (Pubitemid 26119922)
15. Collinet P, Vereecque R, Sabban F, et al: In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice. J Obstet Gynaecol Res 32: 449-453, 2006.
16. Minaguchi T, Mori T, Kanamori Y, et al: Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene. Cancer Res 59: 6063-6067, 1999. (Pubitemid 30035621)
17. Bao JJ, Le XF, Wang RY, et al: Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res 62: 7264-7272, 2002.
18. Tan WL, Xiong L, Zheng SB, et al: Relationship between programmed cell death 5 protein expression and prognosis of renal clear cell carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 26: 1316-1318, 2006.
19. Jiang TB, Li X, Zhou J, et al: Expression of PDCD5 in multiple myeloma and its relation with BCL-2. Zhong Nan Da Xue Xue Bao Yi Xue Ban 33: 814-820, 2008.
20. Chen LN, Wang Y, Ma DL and Chen Y: Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression. Apoptosis 11: 101-111, 2006. (Pubitemid 43151648)